Timothy Coetzee - Articles and news items

Biogen Idec logo

Biogen Idec’s TECFIDERA™ approved in US as a first-line oral treatment for multiple sclerosis

Industry news, News / 27 March 2013 / Biogen Idec

The U.S. FDA has approved TECFIDERA™…

Genzyme logo

FDA approves Genzyme’s AUBAGIO®

Industry news, News / 12 September 2012 / Sanofi

AUBAGIO® (teriflunomide), a once-daily, oral treatment for relapsing Multiple Sclerosis…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+